Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Raymond Fong,1 Megan E Cavet,2 Heleen H DeCory,2 Jason L Vittitow31Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital, New York, NY, USA; 2Medical Affairs, Bausch + Lomb, Rochester, NY, USA; 3Clinical Affairs, Bausch + Lomb, Bridgewater, NJ, USAPurpose: To evaluate the efficacy and safet...

Full description

Bibliographic Details
Main Authors:	Fong R, Cavet ME, DeCory HH, Vittitow JL
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-08-01
Series:	Clinical Ophthalmology
Subjects:	Cataract surgery Postoperative pain Postoperative inflammation Loteprednol etabonate Submicron Integrated analysis
Online Access:	https://www.dovepress.com/loteprednol-etabonate-submicron-ophthalmic-gel-038-dosed-three-times-d-peer-reviewed-article-OPTH

Similar Items

Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
by: Sheppard JD, et al.
Published: (2019-07-01)

A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty
by: Khaimi MA
Published: (2018-02-01)

A Comparative Study of Efficacy and Safety of Topical Loteprednol Etabonate 0.5% and Cyclosporin A 0.05% for the Treatment of Vernal Keratoconjunctivitis
by: Sharika Ganjoo, et al.
Published: (2020-12-01)

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
by: Bian, Y., et al.
Published: (2022)

Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
by: Gökçen Özcan, et al.
Published: (2021-04-01)

Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery
by: Kim T, et al.
Published: (2018-12-01)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01)

Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper
by: Mifflin MD, et al.
Published: (2017-06-01)

Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop
by: Coffey MJ, et al.
Published: (2013-02-01)

Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
by: Timothy L. Comstock, et al.
Published: (2012-01-01)

Comparison of loteprednol with fluorometholone after myopic photorefractive keratectomy
by: Farid Karimian, et al.
Published: (2017-01-01)

Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate
by: Dimal A. Shah, et al.
Published: (2021-04-01)

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin
by: Robert Dobbins, et al.
Published: (2021-06-01)

Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery
by: Jagadeesh Kumar Reddy, et al.
Published: (2019-05-01)

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy
by: Mohan V, et al.
Published: (2020-06-01)

Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
by: Shaveta Singla, et al.
Published: (2019-01-01)

Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
by: Timothy L Comstock, et al.
Published: (2011-02-01)

The effect of loteprednol suspension eye drops after corneal transplantation
by: Yingxin Chen, et al.
Published: (2021-05-01)

Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
by: Marlowe ZT, et al.
Published: (2013-12-01)

An update on the surgical management of pterygium and the role of loteprednol etabonate ointment
by: Sheppard JD, et al.
Published: (2014-06-01)

Reentrainment of Submicron Solid Particles
by: Mortazavi, Ramin
Published: (2005)

SUBMICRON PARTICLES EMISSION CONTROL BY ELECTROSTATIC AGGLOMERATION
by: Andrzej Krupa, et al.
Published: (2017-04-01)

Separation and characterization of environmental nano- and submicron particles
by: Ermolin Mikhail S., et al.
Published: (2016-12-01)

Pharmacokinetic performance of the nitrendipine intravenous submicron emulsion in rats
by: Jibin Guan, et al.
Published: (2014-12-01)

Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial
by: Fong R, et al.
Published: (2012-07-01)

Recrystallization and Production of Spherical Submicron Particles of Sulfasalazine Using a Supercritical Antisolvent Process
by: Wei-Yi Wu, et al.
Published: (2018-07-01)

Spatiotemporal Variation in Composition of Submicron Particles in Santiago Metropolitan Region, Chile
by: Matías Tagle, et al.
Published: (2018-05-01)

THE FEASIBILITY STUDY OF W-Cu COMPOSITE PRODUCTION BY SUBMICRON PARTICLES ADDITION AND INFILTRATION
by: S. Borji, et al.
Published: (2017-03-01)

Use of Pulse-Energized Electrostatic Precipitator to Remove Submicron Particulate Matter in Exhaust Gas
by: Vishnu Thonglek, et al.
Published: (2014-09-01)

EQUIPMENT FOR NONDESTRUCTIVE TESTING OF SILICON WAFERS SUBMICRON TOPOLOGY DURING THE FABRICATION OF INTEGRATED CIRCUITS
by: S. A. Chizhik, et al.
Published: (2015-03-01)

Mechanochemical synthesis of chitosan submicron particles from the gladius of Todarodes pacificus
by: J.R. Anusha, et al.
Published: (2016-11-01)

Mechanism of texture formation in submicron Cu thin films
by: X.W. Peng, et al.
Published: (2021-11-01)

Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery
by: Saeed Shokoohi-Rad, et al.
Published: (2018-06-01)

The experience of using dexmedetomidine as an adjuvant of anesthesia in ophthalmic surgery
by: N.V. Mynka, et al.
Published: (2021-03-01)

Atmospheric Measurements of Submicron Aerosols at the California-Mexico Border and in Houston, Texas
by: Levy, Misti E
Published: (2013)

Comparison of the Outcomes of Manual Small Incision Cataract Surgery (MSICS) and Phacoemulsification (PHACO) in Ghana
by: Samuel Kyei, et al.
Published: (2021-07-01)

Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity
by: Shi C, et al.
Published: (2020-02-01)

Acoustic separation of submicron particles in gaseous flows
by: Imani Jajarmi, Ramin
Published: (2015)

Electrostatic Precipitation of Submicron Particles in a Molten Carrier
by: Adrian Dobrowolski, et al.
Published: (2019-06-01)

Unraveling the properties of sharply defined submicron scale FeCu and FePd magnetic structures fabricated by electrodeposition onto electron-beam-lithographed substrates
by: Evangelia Dislaki, et al.
Published: (2020-08-01)